HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$1.94
Day range
$1.95 - $2.20
Year range
$1.75 - $17.84
Market cap
4.00M USD
Avg Volume
677.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.19M | -30.87% |
Net income | -2.19M | 30.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.15M | 30.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.68M | 108.72% |
Total assets | 5.10M | 65.32% |
Total liabilities | 918.40K | -38.35% |
Total equity | 4.18M | — |
Shares outstanding | 1.89M | — |
Price to book | 0.49 | — |
Return on assets | -115.98% | — |
Return on capital | -143.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.19M | 30.45% |
Cash from operations | -1.78M | -36.09% |
Cash from investing | — | — |
Cash from financing | 2.69M | 480.25% |
Net change in cash | 919.90K | 205.66% |
Free cash flow | -930.39K | -2,547.00% |
About
Founded
1994
Website
Employees
6
